Abdel-Messih, H.A., Ishak, R.A.H., Geneidi, A.S., Mansour, S., Tailoring novel soft nano-vesicles 'Flexosomes' for enhanced transdermal drug delivery: optimization, characterization and comprehensive ex vivo - in vivo evaluation. Int. J. Pharm. 560 (2019), 101–115, 10.1016/j.ijpharm.2019.01.072.
Abdulbaqi, I.M., Darwis, Y., Khan, N.A.K., Assi, R.A., Khan, A.A., Ethosomal nanocarriers: the impact of constituents and formulation techniques on ethosomal properties, in vivo studies, and clinical trials. Int. J. Nanomed. 11 (2016), 2279–2304, 10.2147/IJN.S105016.
AdminMed®. AdminStamp® Microneedle Array Device. http://adminmed.com/adminstamp (accessed 12 March 2019).
Bellefroid, C., Lechanteur, A., Evrard, B., Piel, G., Lipid gene nanocarriers for the treatment of skin diseases: current state-of-the-art. Eur. J. Pharm. Biopharm., 2019, 10.1016/j.ejpb.2019.02.012.
Bibi, N., Ahmed, N., Khan, G., Nanostructures in transdermal drug delivery systems. Grumezescu, A.M., (eds.) Nanostructures for Drug Delivery, 2017, Elsevier, 639–668, 10.1016/b978-0-323-46143-6.00021-x.
Bolzinger, M.-A., Briançon, S., Pelletier, J., Chevalier, Y., Penetration of drugs through skin, a complex rate-controlling membrane. Curr Opin Colloid In. 173 (2012), 156–165, 10.1016/j.cocis.2012.02.001.
Cevc, G., Blume, G., Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. BBA-Biomembranes 11041 (1992), 226–232, 10.1016/0005-2736(92)90154-E.
Cevc, G., Blume, G., New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, Transfersomes. BBA-Biomembranes 15142 (2001), 191–205, 10.1016/S0005-2736(01)00369-8.
Chen, B.Z., Yang, Y., Wang, B.B., Ashfaq, M., Guo, X.D., Self-implanted tiny needles as alternative to traditional parenteral administrations for controlled transdermal drug delivery. Int. J. Pharm. 556 (2019), 338–348, 10.1016/j.ijpharm.2018.12.019.
Chen, W., Li, H., Shi, D., Liu, Z., Yuan, W., Microneedles as a delivery system for gene therapy. Front. Pharmacol., 7, 2016, 137, 10.3389/fphar.2016.00137.
Dayan, N., Touitou, E., Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. Biomaterials 2118 (2000), 1879–1885, 10.1016/S0142-9612(00)00063-6.
El Maghraby, G.M., Barry, B.W., Williams, A.C., Liposomes and skin: from drug delivery to model membranes. Eur. J. Pharm. Sci. 344:5 (2008), 203–222, 10.1016/j.ejps.2008.05.002.
El Zaafarany, G.M., Awad, G.A., Holayel, S.M., Mortada, N.D., Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery. Int. J. Pharm. 3971:2 (2010), 164–172, 10.1016/j.ijpharm.2010.06.034.
Elsayed, M.M., Abdallah, O.Y., Naggar, V.F., Khalafallah, N.M., Lipid vesicles for skin delivery of drugs: reviewing three decades of research. Int. J. Pharm. 3321:2 (2007), 1–16, 10.1016/j.ijpharm.2006.12.005.
Geusens, B., Van Gele, M., Braat, S., De Smedt, S., Stuart, M., Prow, T., Sanchez, W., Roberts, M., Sanders, N., Lambert, J., Flexible nanosomes (SECosomes) enable efficient siRNA delivery in cultured primary skin cells and in the viable epidermis of ex vivo human skin. Adv. Funct. Mater. 20 (2010), 4077–4090, 10.1002/adfm.201000484.
Gillet, A., Grammenos, A., Compere, P., Evrard, B., Piel, G., Development of a new topical system: drug-in-cyclodextrin-in-deformable liposome. Int. J. Pharm. 3801:2 (2009), 174–180, 10.1016/j.ijpharm.2009.06.027.
Godin, B., Touitou, E., Mechanism of bacitracin permeation enhancement through the skin and cellular membranes from an ethosomal carrier. J. Control. Release 942:3 (2004), 365–379, 10.1016/j.jconrel.2003.10.014.
Hussain, A., Singh, S., Sharma, D., Webster, T.J., Shafaat, K., Faruk, A., Elastic liposomes as novel carriers: recent advances in drug delivery. Int. J. Nanomed. 12 (2017), 5087–5108, 10.2147/IJN.S138267.
Ibaraki, H., Kanazawa, T., Takashima, Y., Okada, H., Seta, Y., Transdermal anti-nuclear kappaB siRNA therapy for atopic dermatitis using a combination of two kinds of functional oligopeptide. Int. J. Pharm. 5421 (2018), 213–220, 10.1016/j.ijpharm.2018.03.026.
Ibaraki, H., Kanazawa, T., Oogi, C., Takashima, Y., Seta, Y., Effects of surface charge and flexibility of liposomes on dermal drug delivery. J. Durg Deliv. Sci. Tech. 50 (2019), 155–162, 10.1016/j.jddst.2019.01.028.
Jin, X., Zhu, D.D., Chen, B.Z., Ashfaq, M., Guo, X.D., Insulin delivery systems combined with microneedle technology. Adv. Drug Deliv. Rev. 127 (2018), 119–137, 10.1016/j.addr.2018.03.011.
Jose, A., Labala, S., Venuganti, V.V., Co-delivery of curcumin and STAT3 siRNA using deformable cationic liposomes to treat skin cancer. J. Drug Target. 254 (2017), 330–341, 10.1080/1061186X.2016.1258567.
Kalluri, H., Kolli, C.S., Banga, A.K., Characterization of microchannels created by metal microneedles: formation and closure. AAPS J. 133 (2011), 473–481, 10.1208/s12248-011-9288-3.
Lan, X., She, J., Lin, D.A., Xu, Y., Li, X., Yang, W.F., Lui, V.W.Y., Jin, L., Xie, X., Su, Y.X., Microneedle-mediated delivery of lipid-coated cisplatin nanoparticles for efficient and safe cancer therapy. ACS Appl. Mater. Interfaces 1039 (2018), 33060–33069, 10.1021/acsami.8b12926.
Lechanteur, A., Sanna, V., Duchemin, A., Evrard, B., Mottet, D., Piel, G., Cationic liposomes carrying siRNA: impact of lipid composition on physicochemical properties, cytotoxicity and endosomal escape. Nanomaterials., 85, 2018, 10.3390/nano8050270.
Limsuwan, T., Amnuaikit, T., Development of ethosomes containing mycophenolic acid. Procedia Chem. 4 (2012), 328–335, 10.1016/j.proche.2012.06.046.
McCaffrey, J., McCrudden, C.M., Ali, A.A., Massey, A.S., McBride, J.W., McCrudden, M.T., Vicente-Perez, E.M., Coulter, J.A., Robson, T., Donnelly, R.F., McCarthy, H.O., Transcending epithelial and intracellular biological barriers; a prototype DNA delivery device. J. Control. Release 226 (2016), 238–247, 10.1016/j.jconrel.2016.02.023.
Qiu, Y., Gao, Y., Hu, K., Li, F., Enhancement of skin permeation of docetaxel: a novel approach combining microneedle and elastic liposomes. J. Control. Release 1292 (2008), 144–150, 10.1016/j.jconrel.2008.04.019.
Seok, H., Noh, J.Y., Lee, D.Y., Kim, S.J., Song, C.S., Kim, Y.C., Effective humoral immune response from a H1N1 DNA vaccine delivered to the skin by microneedles coated with PLGA-based cationic nanoparticles. J. Control. Release 265 (2017), 66–74, 10.1016/j.jconrel.2017.04.027.
Su, R., Fan, W., Yu, Q., Dong, X., Qi, J., Zhu, Q., Zhao, W., Wu, W., Chen, Z., Li, Y., Lu, Y., Size-dependent penetration of nanoemulsions into epidermis and hair follicles: implications for transdermal delivery and immunization. Oncotarget 824 (2017), 38214–38226, 10.18632/oncotarget.17130.
Touitou, E., Dayan, N., Bergelson, L., Godin, B., Eliaz, M., Ethosomes- novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J. Control. Release 65 (2000), 403–418, 10.1016/s0168-3659(99)00222-9.
Van Der Maaden, K., Jiskoot, W., Bouwstra, J., Microneedle technologies for (trans)dermal drug and vaccine delivery. J. Control. Release 1612 (2012), 645–655, 10.1016/j.jconrel.2012.01.042.
Verma, P., Pathak, K., Nanosized ethanolic vesicles loaded with econazole nitrate for the treatment of deep fungal infections through topical gel formulation. Nanomedicine 84 (2012), 489–496, 10.1016/j.nano.2011.07.004.
Waghule, T., Singhvi, G., Dubey, S.K., Pandey, M.M., Gupta, G., Singh, M., Dua, K., Microneedles: a smart approach and increasing potential for transdermal drug delivery system. Biomed. Pharmacother. 109 (2019), 1249–1258, 10.1016/j.biopha.2018.10.078.
Zakrewsky, M., Kumar, S., Mitragotri, S., Nucleic acid delivery into skin for the treatment of skin disease: Proofs-of-concept, potential impact, and remaining challenges. J. Control. Release 219 (2015), 445–456, 10.1016/j.jconrel.2015.09.017.
Zhu, D.D., Zhang, X.P., Yu, H.L., Liu, R.X., Shen, C.B., Zhang, W.F., Cui, Y., Guo, X.D., Kinetic stability studies of HBV vaccine in a microneedle patch. Int. J. Pharm., 567, 2019, 118489, 10.1016/j.ijpharm.2019.118489.
